bpc 157 benefits risks BPC-157 Explained: Benefits, Safety & Oral vs Injectable Options BPC-157 benefits, dosage, and side

AOD 9604 doesn't affect IGF-1 levels, so there's no concern about unwanted tissue growth or increased cancer risk

The FDA classifies BPC-157 as a Category 2 bulk drug substance meaning its not FDA-approved for human use and has been flagged as potentially presenting safety risks in unregulated compounding

Phase I human trial of parent molecule (TB-4) showed no serious adverse events Mild injection site reactions possible Same theoretical angiogenesis/tumor concern as BPC-157 Head rush or lightheadedness reported anecdotally at higher doses Can You Stack BPC-157 and TB-500

By targeting both the inflammation and tissue repair processes, BPC-157 can significantly reduce pain and enhance recovery time

This is the standard used in most of Europe